Trials / Completed
CompletedNCT06742242
The Use of Non-ICG-Enhanced Lymphatic Vessels for LVA
The Use of Non-Indocyanine Green-Enhanced Lymphatic Vessels for Supermicrosurgical Lymphaticovenous Anastomosis: a Propensity-Score-Matched Outcome Analysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the present study was to investigate the impact of non-ICG(+) LVs on the outcomes after LVA compared to ICG(+) LVs with propensity-score-match analysis.
Detailed description
It is a common belief among lymphatic supermicrosurgeons that LVA should only be performed with indocyanine green-enhanced (ICG(+)) LVs since such LVs are considered functional and are suitable for achieving better outcomes. However, in moderate to advance lymphedema patients, the use of non-ICG(+) LVs are inevitable despite efforts to identified ICG(+) LVs with ICG lymphography10, magnetic resonance (MR) lymphangiography11, or ultrasound12. In a previous study, it was suggested that a non-ICG(+) but flow-positive LV should also be considered functional because the functionality of an LV should be determined by its capability to transport lymph instead of ICG(+) lymph. Therefore, non- ICG(+) but flow-positive LVs should also be used for LVA to maximize the outcome13. This hypothesis was further supported by a recent article emphasizing the concept of a lymphatic-based lymphosome14, where it has been demonstrated that a functional LV will not become ICG(+) when ICG is not injected in the region being drained by this particular LV. It offers an explanation as to why a supposedly functional LV is not enhanced by ICG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | lymphaticovenous anastomosis | supermicrosurgical lymphatic vessel to recipient ven lumen-to-lumen coaptation |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2024-12-19
- Last updated
- 2024-12-19
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06742242. Inclusion in this directory is not an endorsement.